The global burden of mental, neurological and substance use disorders: An analysis from the global burden of disease study 2010

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Whiteford, Harvey A ^a,b,c   Ferrari, Alize J ^a,b,c   Degenhardt, Louisa ^c,d,e   Feigin, Valery ^f   Vos, Theo ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Queensland Centre for Mental Health Research   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; OPIATE;

AGE; ALCOHOLISM; ALZHEIMER DISEASE; ANXIETY DISORDER; ARTICLE; ASIA; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONDUCT DISORDER; DEATH; DISABILITY ADJUSTED LIFE YEAR; DRUG DEPENDENCE; DYSTHYMIA; EASTERN EUROPE; EATING DISORDER; EPILEPSY; HUMAN; INTELLECTUAL IMPAIRMENT; LIFE EXPECTANCY; MAJOR DEPRESSION; MENTAL DISEASE; MIGRAINE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OPIATE ADDICTION; PACIFIC ISLANDS; PARKINSON DISEASE; PREVALENCE; QUALITY OF LIFE; SCHIZOPHRENIA; SUBSTANCE ABUSE; TENSION HEADACHE; TREND STUDY; YEARS LIVED WITH DISABILITY; YEARS LOST TO PREMATURE MORTALITY; BAYES THEOREM; COST OF ILLNESS; ECONOMICS; FEMALE; GEOGRAPHY; HEALTH; MALE; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PREMATURE MORTALITY; QUALITY ADJUSTED LIFE YEAR; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; TIME FACTOR;

AGE FACTORS; BAYES THEOREM; COST OF ILLNESS; FEMALE; GEOGRAPHY; GLOBAL HEALTH; HUMANS; MALE; MENTAL DISORDERS; MORTALITY, PREMATURE; NERVOUS SYSTEM DISEASES; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; REGRESSION ANALYSIS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84922740654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116820     Document Type: Article

References (35)

1. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223. doi: 10.1016/S0140-6736(12)61689-4 PMID: 23245608
2. World Health Organization (2008) The global burden of disease: 2004 update. Geneva: World Health Organization.
3. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, et al. (2007) Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. The Lancet 370: 841-850.
4. Wang PS, Angermeyer M, Borges G, Bruffaerts R, Tat Chiu W, et al. (2007) Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6: 177-185. PMID: 18188443
5. Jorm AF (2012) Mental health literacy: empowering the community to take action for better mental health. Am Psychol 67: 231-243. doi: 10.1037/a0025957 PMID: 22040221
6. Cheng AT (2001) Case definition and culture: Are people all the same? Br J Psychiatry 179: 1-3. PMID: 11435259
7. Yang LH, Link BG (2009) Comparing diagnostic methods for mental disorders in China. Lancet 373: 2002-2004. doi: 10.1016/S0140-6736(09)61091-6 PMID: 19524763
8. Whiteford1 HA, Ferrari AJ, Baxter AJ, Charlson FJ, Degenhardt L (2013) How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010? Current Opinion in Psychiatry 26: 376-383. doi: 10.1097/YCO.0b013e328361e60f PMID: 23689547
9. Murray CJL, Lopez AD, editors (1996) The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press. PMID: 25121335
10. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, et al. (2012) Age-specifi c and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2071-2094. doi: 10.1016/S0140-6736(12)61719-X PMID: 23245603
11. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2163-2196. doi: 10.1016/S0140-6736(12)61729-2 PMID: 23245607
12. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, et al. (2012) Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 380: 2144-2162. doi: 10.1016/S0140-6736(12)61690-0 PMID: 23245606
13. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128. doi: 10.1016/S0140-6736(12)61728-0 PMID: 23245604
14. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260. doi: 10.1016/S0140-6736(12)61766-8 PMID: 23245609
15. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, et al. (2013) The Global Burden of Mental and Substance Use Disorders, 2010. The Lancet 382: 1575-1586. doi: 10.1016/S0140-6736(13) 61611-6 PMID: 23993280
16. Baxter AJ, Patton G, Degenhardt L, Scott KM, Whiteford HA (2013) Global epidemiology of mental disorders: what are we missing?. PLOS One 8. doi: 10.1371/journal.pone.0082806 PMID: 24482673
17. Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, et al. (2014) The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010. Drug Alcohol Depend 137: 37-47.
18. Degenhardt L, Bucello C, Calabria B, Nelson P, Roberts A, et al. (2011) What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 117: 85-101. doi: 10.1016/j.drugalcdep.2010.11.032 PMID: 21377813
19. Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, et al. (2014) The global epidemiology and burden of opioid dependence: Results from the Global Burden of Disease 2010 study. Addiction 109: 1320-1333. doi: 10.1111/add.12551 PMID: 24661272
20. Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, et al. (2013) The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLOS One 8: e76635. doi: 10.1371/journal.pone.0076635 PMID: 24204649
21. Ferrari AJ, Baxter AJ, Whiteford HA (2010) A systematic review of the global distribution and availability of prevalence data for bipolar disorder. Journal of Affective Disorders 34: 1-13.
22. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Murray CJL, et al. (2013) Burden of depressive disorders by country, sex, age and year: Findings from the Global Burden of Disease Study 2010. PLOS Medicine 10: e1001547. doi: 10.1371/journal.pmed.1001547 PMID: 24223526
23. Erskine HE, Ferrari AJ, Polanczyk GV, Moffitt TE, Murray CJ, et al. (2014) The global burden of conduct disorder and attention-deficit/hyperactivity disorder in 2010. Journal of Child Psychology and Psychiatry 55: 328-336. doi: 10.1111/jcpp.12186 PMID: 24447211
24. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSMIV- TR). Washington DC: American Psychiatric Association.
25. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization.
26. Murray CJL, Ezzati M, Flaxman A, Lim S, Lozano R, et al. (2012) GBD 2010: design, definitions, and metrics. Lancet 380: 2063-2066. doi: 10.1016/S0140-6736(12)61899-6 PMID: 23245602
27. Ferrari AJ, Charlson FJ, Norman R, Flaxman AD, Patten SB, et al. (2013) The epidemiological modelling of major depressive disorder: Application for the Global Burden of Disease Study 2010. PLOS One 8: e69637. doi: 10.1371/journal.pone.0069637 PMID: 23922765
28. Erskine HE, Ferrari AJ, Nelson P, Polanczyk GV, Flaxman AD, et al. (2013) Research Review: Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. Journal of Child Psychology and Psychiatry 54: 1263-1274. doi: 10.1111/ jcpp.12144 PMID: 24117530
29. Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLOS Medicine 2: e141. PMID: 15916472
30. Lawrence D, Hancock KJ, Kisely S (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. British Medical Journal 346. doi: 10.1136/bmj.f4242 PMID: 23828895
31. Crump C, Winkleby MA, Sundquist K, Sundquist J (2013) Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. American Journal of Psychiatry 170: 324-333. doi: 10.1176/appi.ajp.2012.12050599 PMID: 23318474
32. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA (2005) Epilepsy and mortality in Africa: a review of the literature. Epilepsia 46: 33-35. PMID: 16393176
33. Ferrari AJ, Norman RE, Freedman G, Baxter AJ, Pirkis JE, et al. (2014) The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the global burden of disease study 2010. PLOS One 9: e91936. doi: 10.1371/journal.pone.0091936 PMID: 24694747
34. Murray CJ, Acharya AK (1997) Understanding DALYs. Journal of Health Economics 16: 703-730. PMID: 10176780
35. United Nations (2011) World Population Prospects-The 2010 Revision. New York: United Nations. doi: 10.4414/smw.2014.14059 PMID: 25604846